SIM
Spark Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,700
| Closed | -$396K | – | 135 |
|
|
2020
Q1 | $396K | Sell |
7,700
-300
| -4% | -$15.4K | 0.21% | 155 |
|
|
2019
Q4 | $494K | Buy |
+8,000
| New | +$494K | 0.06% | 350 |
|
|
2019
Q1 | – | Sell |
-3,900
| Closed | -$276K | – | 665 |
|
|
2018
Q4 | $276K | Sell |
3,900
-9,400
| -71% | -$665K | 0.02% | 464 |
|
|
2018
Q3 | $1.14M | Buy |
+13,300
| New | +$1.14M | 0.07% | 364 |
|
|
2018
Q2 | – | Sell |
-43,600
| Closed | -$3.53M | – | 672 |
|
|
2018
Q1 | $3.53M | Buy |
+43,600
| New | +$3.53M | 0.23% | 141 |
|
|
2017
Q3 | – | Sell |
-53,100
| Closed | -$1.91M | – | 735 |
|
|
2017
Q2 | $1.91M | Sell |
53,100
-98,200
| -65% | -$3.53M | 0.12% | 258 |
|
|
2017
Q1 | $4.66M | Sell |
151,300
-39,500
| -21% | -$1.22M | 0.29% | 88 |
|
|
2016
Q4 | $6.39M | Sell |
190,800
-127,700
| -40% | -$4.28M | 0.53% | 33 |
|
|
2016
Q3 | $8.48M | Buy |
318,500
+25,400
| +9% | +$676K | 0.69% | 14 |
|
|
2016
Q2 | $6.46M | Buy |
293,100
+220,300
| +303% | +$4.86M | 0.6% | 19 |
|
|
2016
Q1 | $2.14M | Buy |
+72,800
| New | +$2.14M | 0.22% | 149 |
|
|
2015
Q4 | – | Sell |
-13,900
| Closed | -$502K | – | 776 |
|
|
2015
Q3 | $502K | Buy |
+13,900
| New | +$502K | 0.07% | 375 |
|
|
2014
Q4 | – | Sell |
-35,800
| Closed | -$1.42M | – | 725 |
|
|
2014
Q3 | $1.42M | Buy |
35,800
+22,800
| +175% | +$902K | 0.21% | 155 |
|
|
2014
Q2 | $559K | Buy |
+13,000
| New | +$559K | 0.08% | 335 |
|